Science & Enterprise subscription

Follow us on Twitter

  • A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing thera… https://t.co/HTEdzTQVvO
    about 19 hours ago
  • New post on Science and Enterprise: Industry, Univ Labs Partner on Cannabinoid Pain Drug https://t.co/ZrZF5dm5Ce #Science #Business
    about 19 hours ago
  • https://t.co/037qhZ8zQ2 Go Hawks ... in this case, a sharp-shinned hawk, according to @CornellBirds
    about 22 hours ago
  • An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2… https://t.co/NCatkkRGQq
    about 23 hours ago
  • New post on Science and Enterprise: Simpler Method Devised to Validate Covid-19 Tests https://t.co/PC6JYOVo7T #Science #Business
    about 23 hours ago

Please share Science & Enterprise

NIH Funds Study of Chemical Effects on Adult Stem Cells

Jonathan Dordick (Rensselaer Polytechnic Institute)

Jonathan Dordick (Rensselaer Polytechnic Institute)

Bioengineers at Rensselaer Polytechnic Institute in Troy, New York and University of California at Berkeley, have been awarded a grant from  National Institutes of Health (NIH) to study how chemicals in drugs and the environment affect human stem cells. The four-year grant of more than $2 million will fund teams led by Rensselaer’s chemical and biological engineering professor Jonathan Dordick (pictured left) and Berkeley’s David Schaffer, professor of chemical and biomolecular engineering, who also is co-director of the Berkeley Stem Cell Center.

The researchers expect to test the hypothesis that stem cells, essential for the replacement of dead and damaged tissues in the body, react in different ways to chemicals than other cells in the body. The grant will allow researchers to study the affects of known chemical compounds — like those in drugs, pesticides, and other products — on adult stem cells.

The team also plans to develop a new predictive safety screening tool that manufacturers can use to test the toxicity of new chemical compounds on stem cells before their drug or other product reaches the market. “One of the goals would be that we would add a stem cell screening component,” says Dordick, “to the safety testing of a pharmaceutical candidate or to the assessment of the health effect of a chemical in the environment, say on our food.” The researchers expect to devise the test to work without the use of animals and at faster speeds than current tests.

In the study, researchers expect to use lab-on-a-chip technology that allows for quick testing of thousands of different chemicals on the surface of one simple, small chip, similar in appearance to a traditional glass microscope slide. The chip’s surface has hundreds of microscale spots of stem cell cultures, which will allow for the adding of different chemicals to each of these culture spots. The stem cells will then be analyzed for their reaction.

With this technology, hundreds of different chemicals, including drugs and drug combinations, can be tested on a single chip. The stem cells in the study are expected to be human adult neural stem cells and adult mesenchymal stem cells, grown in connective tissue.

Read more:

*     *     *

Comments are closed.